Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02314000 · ClinicalTrials.gov registry record · NA
Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude
A NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
- 20
- Study locations
NCT02314000: Completed NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
NCT02314000 is a NA study of Chronic Pain that has completed, run by Boston Scientific Corporation. The registered enrollment target is 229 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02314000, a NA study of Chronic Pain, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
- 20
- Study locations
Study Summary
To demonstrate sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Precision Spinal Cord Stimulator (SCS) System at sub-perception amplitude
Primary Outcome
Proportion of subjects with 50% or greater reduction in overall pain intensity from baseline with supra and sub perception amplitude with no increase in average daily medication intake to treat pain
Conditions Studied
Interventions
- DEVICE Precision or Precision Spectra Spinal Cord Stimulator System
Study Locations (20)
Ohio
- University of Cincinnati Physicians Company - Cincinnati
- University Hospitals of Cleveland - Cleveland
- Cleveland Clinic Foundation - Cleveland
- Western Reserve Hospital - Cuyahoga Falls
California
- Coastal Pain & Spinal Diagnostics - Carlsbad
- Kaiser Foundation Hospital - Redwood City - Redwood City
- University of California, Davis Medical Center - Sacramento
Florida
- Clearwater Pain Management - Clearwater
- Tallahassee Neurological Clinic, PA - Tallahassee
Georgia
- Shepherd Center - Atlanta
- Orthopedic Research Foundation - Savannah
Mississippi
- Jackson Anesthesia Pain Center, LLC - Jackson
- Comprehensive Pain & Rehabilitation - Pascagoula
Missouri
- KC Pain Centers - Lee's Summit
- Mercy Medical Research Institute - Springfield
North Carolina
- Vidant Roanoke - Chowan Hospital Pain Center - Ahoskie
- The Center for Clinical Research, LLC - Winston-Salem
Arizona
- MORE Foundation - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-08-07 |
| Phase | NA |
What the finished NCT02314000 record still lists
NCT02314000 is an interventional study that assigns participants to a tested intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Precision or Precision Spectra Spinal Cord Stimulator System is the first listed.
NCT02314000 names 20 study sites across 10 states, led by Ohio, California, Florida.
Frequently Asked Questions
What is clinical trial NCT02314000 about?
NCT02314000 is a clinical study titled "Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude". To demonstrate sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Precision Spinal Cord Stimulator (SCS) System at sub-perception amplitude
What is the current status of trial NCT02314000?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2014-12. Estimated completion is 2018-08-07.
What conditions does trial NCT02314000 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT02314000?
The interventions under investigation include: Precision or Precision Spectra Spinal Cord Stimulator System (DEVICE).
Who is sponsoring clinical trial NCT02314000?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02314000 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02314000's enrollment target sits among peer trials
229 72nd of 301 higher than 230 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia